AMDF Breakthrough Award
The AMDF Breakthrough Award funds innovative, previously unfunded research with the potential to significantly advance treatments or cures for age-related macular degeneration.
Funder: American Macular Degeneration Foundation
Due Dates (Anticipated): November 2026 (Annual application deadline, projected)
Funding Amounts: Varies by project scope, duration, and available resources; no fixed maximum or minimum.
Summary: Supports previously unfunded, innovative research with the potential for major advances in treating or curing age-related macular degeneration.
Description
The AMDF Breakthrough Award, offered by the American Macular Degeneration Foundation, is designed to propel innovative and previously unfunded research that could lead to significant breakthroughs in the treatment or cure of age-related macular degeneration (AMD). The award supports pioneering projects across a range of topics, including disease pathway interventions (such as gene or stem cell therapies, pharmaceutical or nutritional treatments, and lifestyle modifications), vision restoration (including retinal prosthesis development), and the development of early detection or diagnostic tools. The overarching goal is to accelerate progress in understanding and combating AMD by fostering bold, high-impact research.
